A 23 years of uneventful evolution in a heart-transplanted patient with chagasic cardiomyopathy on a two-drug immunosuppressive protocol

Transplantation

Volumn 87, Issue 3, 2009, Pages 454-455

  Andrade Vila, José Henrique ^a,b   Zerbini, Euryclides ^a,b   Bitencourt, Delmont ^a,b   Carvalho, Valeria ^a,b   MacRuz, Radi ^a,b   Da Silva, José Pedro ^a,b   Baumgratz, José Francisco ^a,b   Da Fonseca, Luciana ^a,b   De Souza, Magnus ^a,b   D'Andretta Neto, Carlos ^a,b  

^a HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

^b Rua Maestro Cardim   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BENZNIDAZOLE; CYCLOSPORIN; ENALAPRIL; HYDROCHLOROTHIAZIDE; METHYLPREDNISOLONE SODIUM SUCCINATE; SPIRONOLACTONE; IMMUNOSUPPRESSIVE AGENT;

CHAGAS DISEASE; CONGESTIVE HEART FAILURE; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; FOOT EDEMA; GRAFT RECIPIENT; HEART FAILURE; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MEDICAL SOCIETY; PARASITOSIS; PRIORITY JOURNAL; ADULT; CASE REPORT; DRUG COMBINATION; FOLLOW UP; IMMUNOLOGY; MALE; TREATMENT OUTCOME;

ADULT; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; TREATMENT OUTCOME;

EID: 61849153474     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819790c5     Document Type: Letter

References (22)

1. Marchiori PE, Alexandre PL, Brito N, et al. Late reactivation of Chagas disease presenting in a recipient as an expansive mass lesion in the brain after heart transplantation of chagasic myocadiopathy. J Heart Lung Transpl 2007; 26: 1091.
2. Schijman AG, Vigliano C, Burgos J. Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas' heart disease patient. J Heart Lung Transplant 2000; 19: 1114.
3. Bestetti RB, Cury PM, Theodoropoulos TA. Trypanosoma cruzi myocardial infection reactivation presenting as complete atrioventricular block in a Chagas' heart transplant recipient. Cardiovasc Pathol 2004; 13: 323.
4. Bacal F, Andrade AC, Migueletto BC. Histoplasmosis as a late infectious complication following heart transplantation in a patient with Chagas' disease. Arq Bras Cardiol 2001; 76: 403.
5. Bocchi EA, Higuchi ML, Vieira ML. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease. J Heart Lung Transplant 1998; 17: 399.
6. de Almeida DR, Starling CE, Camargo LF. First guidelines of the Brazilian cardiology society for heart transplantation. V. Complication after heart transplantation. Arq Bras Cardiol 1999; 73(suppl 5): 27.
7. Vazquez MC, Sabbatiello R, Schiavelli R. Chagas' disease and transplantation. Transpl Proc 1996; 28: 3301.
8. Puigbo JJ. Chagas' heart disease: Clinical aspects. Cardiologia 1968; 52: 91.
9. Espinosa R, Carrasco HA, Belandria F. Life expectancy analysis in patients with Chagas' disease: Prognosis after one decade (1973-1983). Int J Cardiol 1985; 8: 45.
10. Okumura M, Amato Neto V, Kitagawa MM. Atividade Terapeutica do Benzonidazol em Camundongos Infectados pelo Trypanosoma Cruzi e Imunodeprimidos por Associaçäo de Ciclosporina com Prednisona. Rev Hosp Clin Fac Med S Paulo 1990; 45: 260.
11. Almeida RD, Carvalho AC, Branco JN. Chagas' disease reactivation after heart transplantation: Efficacy of allopurinol treatment. J Heart Lung Transplant 1996; 15: 988.
12. De Carvalho VB, Sousa EF, Vila JH. Heart transplantation in Chagas' disease. 10 years after the initial experience. Circulation 1996; 94: 1815.
13. Bacal F, Silva CP, Bocchi EA, et al. Mycophenolate mofetil increased Chagas' disease reactivation in heart transplanted patients: Comparison between two different protocols. Am J Transplant 2006; 5: 2017.
14. Rassi A, Amato Neto V, Siqueira AF. Influencia de Corticoide, na Doença de Chagas Cronica, Administrado em Virtude de Afecçöes Associadas. Revista de Sociedade Brasileira de Medicina Tropical 1997; 30: 93.
15. Sinagra A, Riarte A, Lauricella M. Reactivation of chronic T. Cruzi infection after immunosuppressive treatment by cyclosporine A and betametasone. Transplantation 1993; 55: 1431.
16. YacoubS,MacumbiAO,YacoubMH.Neglected tropical cardiomyopathies. I. Chagas disease: Myocardialdisease [Review].Heart 2008;94: 244.
17. Bocchi EA, Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First guidelines group for heart transplantation of the Brazilian society of cardiology. Ann Thorac Surg 2001; 71: 1833.
18. Bocchi EA, Fiorelli A. First guideline group for heart transplantation of the Brazilian society of cardiology. The Brazilian experience with heart transplantation: A multicenter report. J Heart Lung Transplant 2001; 20: 637.
19. Vila JHA, Macruz R, Sampaio FA. Transplante cardíaco em doença de Chagas: Experiência preliminar [Abstract]. Arq Bras Cardiol 1985; 45(suppl 1): 1.
20. Yacoub M, Alivazatos PA, Khaghani A. The use of cyclosporine, azathioprine and ATG with no or low dose steroids for immunossupression of cardiac transplant patients. Transplant Proc 1985; 17: 221.
21. Constanzo-Nordin MR, Swinnen LJ, Fisher SG. Cytomegalovirus infections in heart transplant recipients: Relationship to immunosuppression. J Heart Lung Transplant 1992; 11: 837.
22. Gallino A, Maggiorini M, Kiowski W, et al. Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 1996; 15: 389.